Evaluation of embryotoxicity, mutagenicity, and carcinogenicity risks in new drugs
Evaluation of embryotoxicity, mutagenicity, and carcinogenicity risks in new drugs
Richard Jelínek, Zděnek Rychter, Symposium on Toxicological Testing for Safety of New Drugs (3d 1976 Prague), Olga Benešová, Univerzita Karlova
Details
- OL Work ID
- OL42807854W
Subjects
Abnormalities, Drug-InducedPreclinical Drug EvaluationDrug-Related Side Effects and Adverse ReactionsMutationDrug effectsExperimental NeoplasmsChemically inducedDrugsToxicity testingCongressesTesting